To compare the Thulium fiber laser with the Holmium:YAG laser for kidney stone treatment and review the current literature on Thulium fiber laser lithotripsy, highlighting the significance of this comparison in clinical practice.
Key Findings:
Holmium:YAG laser is the current gold standard for laser lithotripsy due to its advantages in stone fragmentation and safety profile, which are critical for patient outcomes.
Thulium fiber laser operates at a wavelength of 1940 nm, closer to the water absorption peak than Holmium:YAG's 2120 nm, potentially improving stone fragmentation, which could lead to better treatment efficacy.
Thulium fiber laser may offer enhanced ablation mechanisms due to its interaction with water in kidney stones, suggesting a need for further exploration of its clinical applications.
Interpretation:
The Thulium fiber laser presents a promising alternative to Holmium:YAG laser, potentially expanding the capabilities of laser lithotripsy due to its favorable absorption characteristics and ablation mechanisms. However, further studies are essential to validate these findings.
Limitations:
The review did not perform a quantified meta-analysis due to heterogeneity in study outcomes, which may limit the generalizability of the findings.
Limited clinical data on the Thulium fiber laser compared to the established Holmium:YAG laser suggests a need for more comprehensive studies.
Conclusion:
Thulium fiber laser technology may enhance kidney stone treatment, but further research is needed to fully establish its efficacy and safety compared to Holmium:YAG laser, emphasizing its potential impact on clinical practice.
A hallmark of Fox Chase leadership, fellows, residents and faculty is their ability to persevere—to keep climbing the often-difficult ascent of cancer discovery and delivery—no matter what. Meet some of the exceptional researchers, scientists, and clinicians determined to make decisive inroads in cancer care.
